Speaker illustration

Miss Eva M Clavane

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)

Eva began her PhD in October 2020 after obtaining an MSc by Research in Cardiovascular Sciences at the University of Leeds. Prior to this, Eva gained a First Class BSc (with Honours) in Human Biology from The University of Birmingham which included one year studying in Kuala Lumpur, Malaysia.

Targeting BACE1 to restore functional angiogenesis in type 2 diabetes

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Session: Moderated poster 12 - Vascular Diseases


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb